Received Aug 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MENB | MENINGOCOCCAL B (BEXSERO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | — | — |
Possible administration to a 30 YO PX; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of intercepted drug prescribing error in a 30-year-old male patient who received Men B NVS (Bexsero) for prophylaxis. Previously administered products included Pneumonia vaccine (received pneumonia vaccine on an unknown date). Concomitant products included iptacopan hydrochloride monohydrate (Fabhalta). On an unknown date, the patient received Bexsero. On an unknown date, an unknown time after receiving Bexsero, the patient experienced intercepted drug prescribing error (Verbatim: Possible administration to a 30 YO PX). The outcome of the intercepted drug prescribing error was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 23-JUL-2025 Pharmacist reported that they had a patient, who was 30 years old and he was on a medication, the medication was called Fabhalta. It affected the immune system and lower the ability to fight infection, so as part of him being on this medication, he needs to be vaccinated for strepto pneumonia and meningitis. He already got his pneumonia vaccine, they went to do the meningitis and the doctor sent the prescription, you know the Menveo and then the Bexsero. But the problem was that Bexsero, and all the Meningococcal B, all have an age for 10 to 25 years old in their indication, so he was 30. The healthcare professional mentioned that they have not administer the Bexsero vaccine to the patient, however, as this was prescribed by patient seems that the patient will receive the vaccine at the age of 30 years old which led to intercepted product prescribing error.
FABHALTA